Related references
Note: Only part of the references are listed.Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease A NOVEL TOOL FOR THERAPY AND DIAGNOSIS
Oliver Wirths et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases
Oliver Wirths et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
Oliver Wirths et al.
ACTA NEUROPATHOLOGICA (2009)
Amyloidogenic processing of amyloid precursor protein:: Evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-β
Holger Cynis et al.
BIOCHEMISTRY (2008)
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology
Stephan Schilling et al.
NATURE MEDICINE (2008)
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype
Alessandra Piccini et al.
ARCHIVES OF NEUROLOGY (2007)
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain
A. Guentert et al.
NEUROSCIENCE (2006)
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2006)
On the seeding and oligomerization of pGlu-amyloid peptides (in vitro)
Stephan Schilling et al.
BIOCHEMISTRY (2006)
β-amyloid is different in normal aging and in Alzheimer disease
A Piccini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Amino-terminally truncated Aβ peptide species are the main component of cotton wool plaques
L Miravalle et al.
BIOCHEMISTRY (2005)
Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions
S Schilling et al.
FEBS LETTERS (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Intranasal immunotherapy for the treatment of Alzheimer's disease:: Escherichia coli LT and LT(R192G) as mucosal adjuvants
CA Lemere et al.
NEUROBIOLOGY OF AGING (2002)
Share Paper
